Studio Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 0.20 Cr
as on 25-06-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 1101.96%
(FY 2022)
- Ebitda 1420.35%
(FY 2022)
- Net Worth 28.59%
(FY 2022)
- Total Assets 276.45%
(FY 2022)
About Studio Diagnostics
The Corporate was formerly known as Sure Path Diagnostics Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Poonam Deep, Raminder Kaur, and Arun Prakash serve as directors at the Company.
- CIN/LLPIN
U85100DL2021PTC375625
- Company No.
375625
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Studio Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raminder Kaur  | Director | 13-Jan-2021 | Current |
| Arun Prakash | Director | 13-Jan-2021 | Current |
| Poonam Deep | Director | 13-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Studio Diagnostics.
Studio Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 1101.96% increase in profit. The company's net worth Soared by an impressive increase of 28.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Studio Diagnostics?
Unlock access to Studio Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Genetix Biotech Asia Private Limited
Active 23 years 1 monthPoonam Deep, Raminder Kaur and 1 more are mutual person
365Medical Asia Private Limited
Active 1 year 7 monthsPoonam Deep, Raminder Kaur and 1 more are mutual person
Qg Bio Sciences Private Limited
Active 15 years 3 monthsRaminder Kaur and Arun Prakash are mutual person
Pp Androbotiks Private Limited
Active 1 year 3 monthsRaminder Kaur and Arun Prakash are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Studio Diagnostics?
Studio Diagnostics has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Studio Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Studio Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
